Evaluation of the safety and efficacy of clopidogrel sulfate 50mg and clopidogrel sulfate 75mg for the treatment of cerebral infarction.

Trial Profile

Evaluation of the safety and efficacy of clopidogrel sulfate 50mg and clopidogrel sulfate 75mg for the treatment of cerebral infarction.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2012

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Cerebral infarction; Embolism and thrombosis
  • Focus Adverse reactions
  • Acronyms COMPASS
  • Sponsors Sanofi
  • Most Recent Events

    • 26 Jan 2010 Actual number of patients (1110) added as reported by ClinicalTrials.gov record.
    • 16 Nov 2008 Status changed from active, no longer recruiting to completed, as reported on ClinicalTrials.gov
    • 25 Sep 2008 Planned end date (Oct 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top